# Tacrolimus Associated Tremors in Liver Transplantation: Immediate-Release Versus Extended-Release Formulations

> **NCT05089604** · PHASE4 · RECRUITING · sponsor: **University of British Columbia** · enrollment: 124 (estimated)

## Conditions studied

- Liver Transplantation
- Immunosuppression
- Neurotoxicity
- Tremor
- Tacrolimus

## Interventions

- **DRUG:** Tacrolimus, Immediate Release, Oral
- **DRUG:** Tacrolimus Extended Release Oral Tablet

## Key facts

- **NCT ID:** NCT05089604
- **Lead sponsor:** University of British Columbia
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-01-09
- **Primary completion:** 2026-01-01
- **Final completion:** 2026-12-31
- **Target enrollment:** 124 (ESTIMATED)
- **Last updated:** 2024-01-02

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05089604

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05089604, "Tacrolimus Associated Tremors in Liver Transplantation: Immediate-Release Versus Extended-Release Formulations". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT05089604. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*